- Home
- KMDA
KMDA
Kamada Ltd.
as of 12-01-2025 3:59pm EST
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
| Founded: | 1990 | Country: | Israel |
| Employees: | 374 | City: | N/A |
| Market Cap: | 385.3M | IPO Year: | N/A |
| Target Price: | $13.00 | AVG Volume (30 days): | 66.9K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | Dividend Payout Frequency: | N/A | |
| EPS: | 0.35 | EPS Growth: | 30.41 |
| 52 Week Low/High: | $5.54 - $9.15 | Next Earning Date: | 11-10-2025 |
| Revenue: | $174,787,000 | Revenue Growth: | 10.36% |
| Revenue Growth (this year): | 14.49% | Revenue Growth (next year): | 10.12% |
AI-Powered KMDA Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Compare KMDA vs Leading Stocks
See how KMDA stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "KMDA Kamada Ltd. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.